These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 24280110)
1. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL; Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110 [TBL] [Abstract][Full Text] [Related]
2. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL; Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709 [TBL] [Abstract][Full Text] [Related]
3. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG; JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624 [TBL] [Abstract][Full Text] [Related]
4. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Crowley K; Goto S; Ohman EM; Bakris GL; Perlstein TS; Kinlay S; Bhatt DL; Eur Heart J; 2013 Apr; 34(16):1204-14. PubMed ID: 23144048 [TBL] [Abstract][Full Text] [Related]
5. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832 [TBL] [Abstract][Full Text] [Related]
7. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710 [TBL] [Abstract][Full Text] [Related]
8. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Eisen A; Bhatt DL; Steg PG; Eagle KA; Goto S; Guo J; Smith SC; Ohman EM; Scirica BM; J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680665 [TBL] [Abstract][Full Text] [Related]
9. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study]. Mimoso J Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315 [TBL] [Abstract][Full Text] [Related]
10. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM; JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899 [TBL] [Abstract][Full Text] [Related]
12. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Fosbøl EL; Sørensen R; Folke F; Buch P; Gadsbøll N; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C Arch Intern Med; 2009 Jan; 169(2):141-9. PubMed ID: 19171810 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304 [TBL] [Abstract][Full Text] [Related]
14. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657 [TBL] [Abstract][Full Text] [Related]
15. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507 [TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). Schopfer DW; Ku IA; Regan M; Whooley MA Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979 [TBL] [Abstract][Full Text] [Related]
17. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality. Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911 [TBL] [Abstract][Full Text] [Related]
18. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study). Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751 [TBL] [Abstract][Full Text] [Related]
19. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction. Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL; Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]